* Streamline Health Solutions Inc STRM.OQ STRM.O is expected
to show a fall in quarterly revenue when it reports results on
April 21.
* The Alpharetta, Georgia-based company is expected to report a
39.7% decrease in revenue to $2.897 million from $4.81 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Streamline Health
Solutions Inc is for a loss of 6 cents per share. For the same
quarter last year, the company reported a loss of 4 cents per
share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Streamline
Health Solutions Inc is $2.5, about 17.2% above its last
closing price of $2.07.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Oct. 31 2020 -0.07 -0.07 -0.04 Beat 42.9
Jul. 31 2020 -0.04 -0.05 -0.04 Beat 20
Apr. 30 2020 -0.06 -0.06 -0.03 Beat 50
Jan. 31 2020 -0.05 -0.05 -0.04 Beat 20
Oct. 0.01 0.01 -0.01 Missed -300
31 2019
Jul. 31 2019 0.01 0.01 -0.02 Missed -300
Apr. 30 2019 0.02 0.02 0.01 Missed -50
Jan. 31 2019 -0.01 0.01 Beat 200
This summary was machine generated April 19 at 20:36 GMT